COVID-19 and oral lesions, short communication and review

dc.contributor.authorEgido-Moreno, Sonia
dc.contributor.authorValls Roca-Umbert, Joan
dc.contributor.authorJané Salas, Enric
dc.contributor.authorLópez López, José, 1958-
dc.contributor.authorEstrugo Devesa, Albert
dc.date.accessioned2022-02-02T13:54:32Z
dc.date.available2022-02-02T13:54:32Z
dc.date.issued2021-03-01
dc.date.updated2022-02-02T13:54:33Z
dc.description.abstractBackground: The COVID-19 disease first appeared in December 2019 in Wuhan, China. The World Health Organization (WHO) declared the pandemic in March 2020, with 40 million cases and a million deaths in October 2020. COVID-19 also includes manifestations on the skin and mucous mucosal membrane. Objective: To evaluate the prevalence of the oral lesions associated to COVID-19 disease; and evaluate their clinical presentation and the hypothesized etiology. Material and methods: An electronic literature search was performed in PubMed, Scopus and Índice Médico Español databases. The following combination of keywords and Boolean operators were used: 'COVID-19 AND oral manifestations'; 'COVID-19 AND oral lesions'; 'COVID-19 AND mucosal lesions' ; 'COVID-19 AND mucosal manifestations'; 'SARS-COV-2 AND oral manifestations'; 'SARS-COV-2 AND oral lesions'; 'SARS-COV-2 AND mucosal lesions'; 'SARS-COV-2 AND mucosal manifestations'. Furthermore, the bibliography was reviewed to manually include additional articles. The risk of bias in individual studies was assessed by two blinded reviewers using the Joanna Briggs Institute (JBI) and the evidence levels of the articles found will be cataloged according to the level of evidence and grade of recommendation of Oxford Centre for Evidence-Based Medicine (CEBM). Results: 249 articles were found in the Medline / Pubmed database. There are no additional articles in the Scopus and Índice Médico Español databases. We selected 14 articles plus 5 more articles due to manual searching. Patients presented a wide variety of oral manifestations. The most prevalent were lesions with a solution of continuity (n = 48, 73.85%) and the most frequent area was the tongue (n = 41, 52.56%). The preferred treatment for the lesions is a localized one by using rinses. Conclusions: To conclude, after the bibliographic review was performed, we can expect that the COVID-19 disease can cause cutaneous and mucosal lesions as secondary manifestations. Despite more studies being needed to confirm this. Key words:COVID-19, SARS-COV-2, oral lesions, oral manifestations.
dc.format.extent8 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec704358
dc.identifier.issn1989-5488
dc.identifier.pmid33680331
dc.identifier.urihttps://hdl.handle.net/2445/182888
dc.language.isoeng
dc.publisherMedicina Oral SL
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.4317/jced.57981
dc.relation.ispartofJournal of Clinical and Experimental Dentistry, 2021, vol. 13, num. 3, p. 287-294
dc.relation.urihttps://doi.org/10.4317/jced.57981
dc.rights(c) Medicina Oral SL, 2021
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Odontoestomatologia)
dc.subject.classificationCOVID-19
dc.subject.classificationSARS-CoV-2
dc.subject.classificationMucosa oral
dc.subject.classificationFerides i lesions
dc.subject.otherCOVID-19
dc.subject.otherSARS-CoV-2
dc.subject.otherOral mucosa
dc.subject.otherWounds and injuries
dc.titleCOVID-19 and oral lesions, short communication and review
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
704358.pdf
Mida:
1.16 MB
Format:
Adobe Portable Document Format